KEFZOL Drug Patent Profile
✉ Email this page to a colleague
When do Kefzol patents expire, and what generic alternatives are available?
Kefzol is a drug marketed by Acs Dobfar and Lilly and is included in two NDAs.
The generic ingredient in KEFZOL is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kefzol
A generic version of KEFZOL was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KEFZOL?
- What are the global sales for KEFZOL?
- What is Average Wholesale Price for KEFZOL?
Summary for KEFZOL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| Clinical Trials: | 9 |
| Patent Applications: | 3,661 |
| DailyMed Link: | KEFZOL at DailyMed |
Recent Clinical Trials for KEFZOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National University Hospital, Singapore | Phase 3 |
| Tan Tock Seng Hospital | Phase 3 |
| Imperial College Healthcare NHS Trust | Phase 3 |
US Patents and Regulatory Information for KEFZOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acs Dobfar | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 061773-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 062557-001 | Sep 10, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Acs Dobfar | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 061773-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Acs Dobfar | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 061773-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Acs Dobfar | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 061773-005 | Sep 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 062557-002 | Sep 10, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
